Robert Goldberg is Director of the Manhattan Institute's Center for Medical Progress. He argues:

    [When Hillary Clinton, as First Lady, took charge of health care prices] the market value of biotech stocks..went down. So too did the amount of venture capital flowing into startups at the time.

    Indeed, the amount of money going into biotech declined more sharply when Hillary was threatening price controls than at any other time since biotech has been around. Seventy-five percent of them had two years of cash or less left in large part because, as the head of the biotech trade group BIO testified at the time, investors were scared by the de facto price controls in the administration's health-care plan.

    And the price controls Hillary did get passed in the Vaccines for Children Program were cited by the Institute of Medicine in 2001 as one reason the vaccine industry is stagnant and unprofitable. Who wants to invest in products knowing your prices are going to be frozen for a decade?

    Then there is Children's Health Care Insurance Plan Hillary loves to take credit for. This program provides federal money to set up state run low cost insurance programs for working class kids. It was supposed to insure nearly nine million children.

    Guess what? Under her stewardship kids were first dumped from Medicaid and then re-enrolled into SCHIP programs. And then it took four years to enroll three million children. And at the same time, private companies dumped coverage for kids and many parents simply stopped insuring their kids at all.